Key facts
- This page summarizes Winston Kung's Form 4 filing for PMV Pharmaceuticals, Inc. (PMVP).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 15 May 2023, 17:56.
Winston Kung - 12 May 2023 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)
- Reporting relationship
- COO, CFO
- Issuer ticker
- PMVP
- Reported as of
- 12 May 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 May 2023, 17:56:13 UTC
- Prior SEC filing
- 30 Jan 2023
- Next SEC filing
- 16 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Winston Kung
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Winston Kung filed Form 4 for PMV Pharmaceuticals, Inc. (PMVP) on 15 May 2023.
Change
- Previous filing in this sequence was filed on 30 Jan 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PMVP
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +150,000
- Change %
- Price
- $0.000000
- Shares after
- 150,000
- Date
- 12 May 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 150,000
- Exercise price
- $5.70
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023.